发明名称 CRKL TARGETING PEPTIDES
摘要 Provided are methods and compositions for selectively targeting CRKL through the use of targeting peptides. Selective targeting of secreted CRKL through the use of a targeting peptide may be used, for example, in the treatment of cancer to deliver a chemotherapeutic compound, fusion protein, or fusion construct to a cancer cell or tissue.
申请公布号 US2011189095(A1) 申请公布日期 2011.08.04
申请号 US200913000231 申请日期 2009.06.19
申请人 THE BOARD OF REGENTS, OF THE UNIVERSITY OF TEXAS SYSTEM 发明人 ARAP WADIH;MINIZ PAUL J.;PASQUALINI RENATA
分类号 A61K38/02;A61K49/00;A61P35/00;A61P35/02;C07K1/04;C07K2/00;C07K7/06;C07K7/08;C07K14/47;C07K14/525;C07K14/535;C07K14/54;C07K14/545;C07K14/55;C07K14/555;C07K14/56;C07K14/565;C07K14/57;C07K16/00;C07K19/00;C12N1/16;C12N1/20;C12N5/07;C12N5/071;C12N7/00;C12N9/96;C12Q1/02 主分类号 A61K38/02
代理机构 代理人
主权项
地址